 |
 |
 |
 |
 |
|
|
| Article 1 to 10 out of 7248
|
03 Jul 2009
-
Cancer geneticist Janet Davison Rowley to receive $500,000 Gruber genetics prize
(03 Jul 2009)
Janet Davison Rowley, MD, a founder in the field of cancer cytogenetics, will receive the 2009 Genetics Prize of The Peter and Patricia Gruber Foundation. She is being honored with the prestigious international award for discoveries of ...
-
Study shows that a combination of common genetic variations can lead to schizophrenia
(03 Jul 2009)
A multi-national group of investigators, including a scientist at the University of North Carolina at Chapel Hill, has discovered that nearly a third of the genetic basis of schizophrenia may be attributed to the cumulative actions of thousands ...
-
GENEART Again Honored with "BAVARIA'S BEST 50" Award
(03 Jul 2009)
GENEART is among the 50 most dynamic companies in Bavaria
GENEART AG is among the 50 most dynamic companies in Bavaria and has been awarded "BAVARIA'S BEST 50" by the Bavarian State Ministry for the third time. Since its market entry in 2000, GENEART evolved to the world market leader in synthetic ...
-
Lu AA24530 shows positive results in major depressive disorder phase II study
(03 Jul 2009)
H. Lundbeck A/S announced positive headline results from a dose finding clinical trial with the compound Lu AA24530 for the treatment of major depressive disorder (MDD). The primary objective of the study was to compare the efficacy of three ...
-
IOP announces 2009 award winners
(03 Jul 2009)
Successful business applications such as drug screening technologies, flat-panel displays and solar-cell designs are amongst the achievements in physics recognised by the Institute of Physics' (IOP) 2009 awards along with leading research in a ...
-
Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research
(03 Jul 2009)
Johnson & Johnson announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin® ...
-
Alzheimer's research yields potential drug target
(03 Jul 2009)
Scientists at UC Santa Barbara and several other institutions have found laboratory evidence that a cluster of peptides may be the toxic agent in Alzheimer's disease. Scientists say the discovery may lead to new drugs for the disease. In an ...
-
Genetically engineered mice yield clues to 'knocking out' cancer
(03 Jul 2009)
Deleting two genes in mice responsible for repairing DNA strands damaged by oxidation leads to several types of tumors, providing additional evidence that such stress contributes to the development of cancer. That's the conclusion of a study in ...
-
NIST issues human milk and blood serum SRMs for contaminant measurements
(03 Jul 2009)
Responding to scientists' need to measure organic contaminants in human body fluids, the National Institute of Standards and Technology (NIST) has recently made four new Standard Reference Materials (SRMs) available for purchase. Developed in ...
-
Comprehensive and User-Friendly Biotech News, Constantly Updated
(03 Jul 2009)
Bionity.COM expands its daily news coverage
BionityCOM, an online information portal provided by Chemie.DE Information Service GmbH, now offers the most comprehensive coverage of news for the biotech and pharma industries in Europe. Bionity.COM's specialist editorial team repeatedly ...
|
|
|
|
|